Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder

Archive ouverte

Etienne, Anne | Gelsi-Boyer, Véronique | Carbuccia, Nadine | Adélaïde, José | Barba, Gianluca | La Starza, Roberta | Murati, Anne | Eclache, Virginie | Birg, Françoise | Birnbaum, Daniel | Mozziconacci, Marie-Joëlle | Mecucci, Christina | Chaffanet, Max

Edité par CCSD ; Elsevier -

International audience. Tyrosine kinases activated by mutation or translocation are involved in the chronic phase of myeloproliferative disorders. Complementary or alternative events are not so well characterized. We report here a case of t(8;13) generating a ZNF198-FGFR1 fusion kinase gene on the derivative chromosome 13. ZNF198-FGFR1 mRNA, but not FGFR1-ZNF198, was detected by polymerase chain reaction amplification. By using fluorescence in situ hybridization with BAC clones, we mapped a deletion of about 2 megabases on the derivative chromosome 8, including the reciprocal FGFR1-ZNF198 fusion gene and the surrounding genes from 8p11 and 13q12. Potential tumor suppressor genes affected by the deletion by loss (IFT88, CRYL1, TACC1) or break (LATS2) may participate in the malignant process.

Consulter en ligne

Suggestions

Du même auteur

Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia

Archive ouverte | Murati, Anne | CCSD

International audience

Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes

Archive ouverte | Etienne, Anne | CCSD

International audience. We report two cases of translocation associated with deletion on derivative chromosomes in atypical myeloproliferative disorder (MPD). In a MPD with t(3;12)(q29;q14), the rearrangement target...

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia

Archive ouverte | Gelsi-Boyer, Véronique | CCSD

International audience. The myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal haematological diseases characterized by ineffective haematopoiesis and predisposition to acute myeloid leukaemia (AML...

Chargement des enrichissements...